Novavax is “actively exploring” to divest its manufacturing facility in the Czech Republic as the company continues to face dwindling demand for its vaccines, CFO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.